This comparative study aims to compare and assess the safety, efficacy, outcome, feasibility, intraoperative and postoperative complications of one-shot dilatation versus serial dilatation techniques for access during percutaneous nephrolithotomy for management of renal stone disease in adult patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mean Fluoroscopy time
Timeframe: From enrollment to the end of treatment at 8 weeks
Mean access time
Timeframe: From enrollment to the end of treatment at 8 weeks
Stone free rate
Timeframe: From enrollment to the end of treatment at 8 weeks
Hospitalization Period
Timeframe: From enrollment to the end of treatment at 8 weeks